Van Denend Toni, Mathiowetz Virgil, Preissner Katharine, Bethoux Francois, Finlayson Marcia, Packer Tanya, Ghahari Setareh, Plow Matthew
Department of Occupational Therapy, University of Illinois Chicago, Chicago, IL.
Program in Occupational Therapy, University of Minnesota, Minneapolis, MN.
Arch Rehabil Res Clin Transl. 2024 Mar 29;6(2):100337. doi: 10.1016/j.arrct.2024.100337. eCollection 2024 Jun.
To describe the adaptations made and to examine interrater reliability and feasibility of administering a telehealth version of the Multiple Sclerosis Functional Composite (tele-MSFC).
The Multiple Sclerosis Functional Composite (MSFC) is a commonly used, in-person clinical outcome assessment. It is composed of the timed 25-Foot Walk Test (T25FWT), Nine-Hole Peg Test (NHPT), and Paced Auditory Serial Addition Test (PASAT). The MSFC was adapted for videoconference administration as part of a larger clinical trial. One of the adaptations included administering a timed 12.5-Foot Walk Test (T12.5FWT) for participants who did not have adequate space in their homes for the T25FWT. Participants, examiners, and raters completed surveys online about their satisfaction and experience with tele-MSFC.
Participants underwent the tele-MSFC in their homes using a laptop or smartphone while examiners scored the tele-MSFC in real-time at a remote location.
Community-dwelling adults (n=61) with mild-to-moderate multiple sclerosis (MS) symptoms.
Not applicable.
Tele-MSFC.
Intraclass correlation coefficients (ICC) assessed interrater reliability between the examiner and 2 independent raters who later scored a recording of the tele-MSFC. Interrater reliability was excellent (ICC>0.90) for all tests, including the T12.5FWT. Participants were highly satisfied with tele-MSFC. However, challenges included adequate space for T25FWT, technical difficulties, and safety and privacy considerations of individuals with moderate impairments who were requested to have their caregivers present during testing.
The tele-MSFC is reliable and feasible to administer with adaptations for community-dwelling adults with mild to moderate MS symptoms. Further validation of T12.5FWT is needed.
描述所做的调整，并检验远程医疗版多发性硬化功能综合评分（tele-MSFC）的评分者间信度及可行性。
多发性硬化功能综合评分（MSFC）是一种常用的面对面临床结局评估方法。它由25英尺计时步行测试（T25FWT）、九孔插板测试（NHPT）和听觉节律性连续加法测试（PASAT）组成。作为一项更大规模临床试验的一部分，MSFC被改编用于视频会议形式的评估。其中一项调整是，对于家中没有足够空间进行T25FWT测试的参与者，采用12.5英尺计时步行测试（T12.5FWT）。参与者、检查者和评分者在线完成了关于他们对tele-MSFC的满意度和体验的调查。
参与者在家中使用笔记本电脑或智能手机进行tele-MSFC测试，而检查者在远程实时对tele-MSFC进行评分。
有轻至中度多发性硬化（MS）症状的社区居住成年人（n = 61）。
不适用。
tele-MSFC。
组内相关系数（ICC）评估了检查者与2名独立评分者之间的评分者间信度，这2名评分者后来对tele-MSFC的一段记录进行了评分。包括T12.5FWT在内的所有测试，评分者间信度都非常好（ICC>0.90）。参与者对tele-MSFC高度满意。然而挑战包括T25FWT测试所需的足够空间、技术困难，以及中度功能障碍个体在测试期间要求其护理人员在场时的安全和隐私问题。
对于有轻至中度MS症状的社区居住成年人，经过调整后，tele-MSFC的实施是可靠且可行的。需要对T12.5FWT进行进一步验证。
